Save your place

Sign in to WhoBought

Please try again later.

Evolus, Inc. (EOLS) institutional ownership

Latest close $5.55 Jul 20, 2026
Market cap$590M 52-week range SectorHealthcare
Funds holding · Q1 2026
166
reported EOLS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
80 buyers · 86 sellers

Evolus, Inc. (EOLS) price and institutional activity

Dates

Q1 2026

$0 bought by 80 investors
Perceptive Advisors LLCSoleus Capital Management, L.P. +78 more
$0 sold by 86 investors
Schroder Investment Management GroupD. E. Shaw & Co., Inc. +84 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Evolus, Inc. (EOLS) institutional activity · 166

Investor Type Est. change Change Δ Own Date
Perceptive Advisors LLC · New
Change +1.3M Date Q1 2026
Perceptive Advisors LLC New· Q1 2026 +1.3M Q1 2026
Soleus Capital Management, L.P. · Added
Change +1.2M Date Q1 2026
Soleus Capital Management, L.P. Added· Q1 2026 +1.2M Q1 2026
Schroder Investment Management Group · Exited
Change −986K Δ Own −100.0% Date Q1 2026
Schroder Investment Management Group Exited· Q1 2026 −986K −100.0% Q1 2026
D. E. Shaw & Co., Inc. · Reduced
Change −982K Δ Own −63.7% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −982K −63.7% Q1 2026
Tang Capital Management LLC · Reduced
Change −763K Date Q1 2026
Tang Capital Management LLC Reduced· Q1 2026 −763K Q1 2026
Buckley Capital Advisors, LLC · Exited
Change −744K Δ Own −100.0% Date Q1 2026
Buckley Capital Advisors, LLC Exited· Q1 2026 −744K −100.0% Q1 2026
Goldman Sachs Group Inc · Added
Change +736K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +736K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −683K −49.5% Q1 2026
Ecor1 Capital, LLC · Exited
Change −675K Δ Own −100.0% Date Q1 2026
Ecor1 Capital, LLC Exited· Q1 2026 −675K −100.0% Q1 2026
Millennium Management LLC · Reduced
Change −632K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −632K Q1 2026
Nantahala Capital Management, LLC · Added
Change +556K Date Q1 2026
Nantahala Capital Management, LLC Added· Q1 2026 +556K Q1 2026
BNP Paribas Financial Markets · Reduced
Change −551K Date Q1 2026
BNP Paribas Financial Markets Reduced· Q1 2026 −551K Q1 2026
Morgan Stanley · Reduced
Change −491K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −491K Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −461K −57.6% Q1 2026
Hrt Financial LP · Exited
Change −429K Δ Own −100.0% Date Q1 2026
Hrt Financial LP Exited· Q1 2026 −429K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 166

Famous investor activity in Evolus, Inc. (EOLS)

Evolus, Inc. (EOLS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Avelar Rui · Officer Sell −$15K
Price $4.75 Qty −3K Owned 427K Trade date Mar 20, 2026 Filed date Mar 20, 2026
Avelar Rui Officer Sell $4.75 −3K −$15K 427K Mar 20, 2026 Mar 20, 2026
Moatazedi David · Director, Officer Sell −$65K
Price $4.75 Qty −14K Owned 605K Trade date Mar 20, 2026 Filed date Mar 20, 2026
Moatazedi David Director, Officer Sell $4.75 −14K −$65K 605K Mar 20, 2026 Mar 20, 2026
Moatazedi David · Director, Officer Sell −$571K
Price $4.89 Qty −117K Owned 618K Trade date Mar 17, 2026 Filed date Mar 18, 2026
Moatazedi David Director, Officer Sell $4.89 −117K −$571K 618K Mar 17, 2026 Mar 18, 2026
Avelar Rui · Officer Sell −$147K
Price $4.89 Qty −30K Owned 431K Trade date Mar 17, 2026 Filed date Mar 18, 2026
Avelar Rui Officer Sell $4.89 −30K −$147K 431K Mar 17, 2026 Mar 18, 2026
Moatazedi David · Director, Officer 2 operations 0
Owned 67K Trade date Mar 16, 2026 Filed date Mar 18, 2026
Moatazedi David Director, Officer 2 operations 0 67K Mar 16, 2026 Mar 18, 2026
Avelar Rui · Officer 2 operations 0
Owned 9K Trade date Mar 16, 2026 Filed date Mar 18, 2026
Avelar Rui Officer 2 operations 0 9K Mar 16, 2026 Mar 18, 2026
Parschauer Karah Herdman · Director Grant (A) 46K
Owned 78K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Parschauer Karah Herdman Director Grant (A) 46K 78K Feb 17, 2026 Feb 19, 2026
Stewart Brady · Director Grant (A) 46K
Owned 134K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Stewart Brady Director Grant (A) 46K 134K Feb 17, 2026 Feb 19, 2026
Mitchell Tatjana · Officer 3 operations 420K
Owned 121K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Mitchell Tatjana Officer 3 operations 420K 121K Feb 17, 2026 Feb 19, 2026
White Albert G. III · Director Grant (A) 46K
Owned 96K Trade date Feb 17, 2026 Filed date Feb 19, 2026
White Albert G. III Director Grant (A) 46K 96K Feb 17, 2026 Feb 19, 2026
Moatazedi David · Director, Officer 3 operations 1.4M
Owned 458K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Moatazedi David Director, Officer 3 operations 1.4M 458K Feb 17, 2026 Feb 19, 2026
Malik Vikram · Director Grant (A) 46K
Owned 321K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Malik Vikram Director Grant (A) 46K 321K Feb 17, 2026 Feb 19, 2026
Avelar Rui · Officer 3 operations 328K
Owned 95K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Avelar Rui Officer 3 operations 328K 95K Feb 17, 2026 Feb 19, 2026
Gill David N. · Director Grant (A) 46K
Owned 87K Trade date Feb 17, 2026 Filed date Feb 19, 2026
Gill David N. Director Grant (A) 46K 87K Feb 17, 2026 Feb 19, 2026
Moatazedi David · Director, Officer Sell −$75K
Price $7.15 Qty −11K Owned 354K Trade date Dec 22, 2025 Filed date Dec 29, 2025
Moatazedi David Director, Officer Sell $7.15 −11K −$75K 354K Dec 22, 2025 Dec 29, 2025
15 of 19
15 of 19 Sign in to continue to older insider transactions.

Evolus, Inc. (EOLS) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Perceptive Advisors LLC 5.4M
% of shares outstanding 8.5% Filing date Nov 14, 2024
Perceptive Advisors LLC 5.4M 8.5% Nov 14, 2024
Tang Capital Management LLC 4.8M
% of shares outstanding 7.7% Filing date Nov 14, 2024
Tang Capital Management LLC 4.8M 7.7% Nov 14, 2024
Medytox Inc. 3.4M
% of shares outstanding 5.9% Filing date Oct 18, 2023
Medytox Inc. 3.4M 5.9% Oct 18, 2023
BlackRock Inc. 3.3M
% of shares outstanding 5.8% Filing date Jan 29, 2024
BlackRock Inc. 3.3M 5.8% Jan 29, 2024
Tang Capital Partners LP 3.1M
% of shares outstanding 5.4% Filing date Feb 14, 2024
Tang Capital Partners LP 3.1M 5.4% Feb 14, 2024
Vanguard Group Inc 2.9M
% of shares outstanding 5.2% Filing date Feb 13, 2024
Vanguard Group Inc 2.9M 5.2% Feb 13, 2024
Nantahala Capital Management, LLC 2.9M
% of shares outstanding 5.1% Filing date Feb 14, 2024
Nantahala Capital Management, LLC 2.9M 5.1% Feb 14, 2024
Millennium Management LLC 2.6M
% of shares outstanding 4.6% Filing date May 9, 2023
Millennium Management LLC 2.6M 4.6% May 9, 2023
8 of 12

Evolus, Inc. (EOLS) ownership FAQ

Who owns EOLS?

166 reporting institutions disclosed EOLS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.